Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP869581.RAfo7E5VMsaBduhQI0seJt4QtVbATC-F132EkQgKPaZ6k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP869581.RAfo7E5VMsaBduhQI0seJt4QtVbATC-F132EkQgKPaZ6k130_assertion type Assertion NP869581.RAfo7E5VMsaBduhQI0seJt4QtVbATC-F132EkQgKPaZ6k130_head.
- NP869581.RAfo7E5VMsaBduhQI0seJt4QtVbATC-F132EkQgKPaZ6k130_assertion description "[Sydnocarb [(phenylisopropyl)N-phenylcarbamoylsydnonimine; SYD] was introduced to clinical practice in Russia as a psychostimulant drug used for the treatment of asthenia and apathy, which accompany schizophrenia and manic depression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869581.RAfo7E5VMsaBduhQI0seJt4QtVbATC-F132EkQgKPaZ6k130_provenance.
- NP869581.RAfo7E5VMsaBduhQI0seJt4QtVbATC-F132EkQgKPaZ6k130_assertion evidence source_evidence_literature NP869581.RAfo7E5VMsaBduhQI0seJt4QtVbATC-F132EkQgKPaZ6k130_provenance.
- NP869581.RAfo7E5VMsaBduhQI0seJt4QtVbATC-F132EkQgKPaZ6k130_assertion SIO_000772 12105094 NP869581.RAfo7E5VMsaBduhQI0seJt4QtVbATC-F132EkQgKPaZ6k130_provenance.
- NP869581.RAfo7E5VMsaBduhQI0seJt4QtVbATC-F132EkQgKPaZ6k130_assertion wasDerivedFrom befree-20150227 NP869581.RAfo7E5VMsaBduhQI0seJt4QtVbATC-F132EkQgKPaZ6k130_provenance.
- NP869581.RAfo7E5VMsaBduhQI0seJt4QtVbATC-F132EkQgKPaZ6k130_assertion wasGeneratedBy ECO_0000203 NP869581.RAfo7E5VMsaBduhQI0seJt4QtVbATC-F132EkQgKPaZ6k130_provenance.